Cite
HARVARD Citation
Sanborn, R. et al. (n.d.). Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC. Journal for immunotherapy of cancer. p. . [Online].